Sunday 28 June 2020

Lip Augmentation Market Report, Applications, Technology and Forecast

Lip Augmentation Market Segmentation
The global Lip Augmentation Market is segmented based on type, lip fillers, distribution channel, and region. The global market for lip augmentation, by type is segmented into temporary lip augmentation and permanent lip augmentation. The permanent lip augmentation segment is further classified as dermal graft, permanent lip implants, vermilion lip advancement and lip lift. The lip lift segment includes corner lip lift and upper lip lift.
The market, by lip fillers, is segmented into fat injection or lipoinjection, hyaluronic acid fillers, lip collagen injections, platelet-rich plasma (PRP), and others.

Based on distribution channel, the market is segmented into hospital pharmacies, clinics, retail pharmacies, drug stores, online pharmacies, and others.
The hospital pharmacies segment is anticipated to hold the largest market share owing to the increasing demand for cosmetic procedures. The online pharmacies are expected to grow at the highest CAGR owing to the rising cases of cosmetic problems.

Lip Augmentation Market Highlights
The global Lip Augmentation Market size is expected to grow at an approximate CAGR of 10.5% during forecast period, 2018–2023. Rising participation of market players is one of the prominent factors driving the lip augmentation market. Various other factors such as increasing awareness about lip augmentation, rising geriatric population and rising demand for dermal fillers are also expected to propel the growth of the market. However, side effects associated with lip fillers and high cost of treatment can hamper the market growth over the forecast period.

Lip Augmentation Market Regional Analysis

The Americas dominated the global market for lip augmentation owing to the rising geriatric population. According to the Population Reference Bureau report, the number of Americans ages 65 and older is projected to double from 46 million today to over 98 million by 2060. Moreover, rising healthcare spending within the region is also boosting the lip augmentation market. In the US, the total healthcare spending reached USD 3.5 trillion in 2017 and by 2026; it is expected to reach USD 5.7 trillion.

it was estimated that Europe stood second in the global lip augmentation market. This can be attributed to the rising research and development investments and technological advancements. For instance, in 2017, Allergan received FDA approval for its newest hyaluronic acid dermal filler, Juvéderm Vollure XC.
Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing medical tourism industry and increasing technological advancements within the region are boosting the regional markets of the Asia Pacific region.

On the other hand, the Middle East and Africa held least share in the global lip augmentation market due to the low per capita income, especially within the African region.
Lip Augmentation Market Key Players
Some of the key players in the global lip augmentation market are Allergan, Galderma Pharma S.A., Integra Lifesciences, Laboratories Vivacy SAS, Merz Pharma, Sinclair Pharma, Suneva Medical, Inc, Teoxane, Cynosure, Syneron, AQTIS Medical, Bioha Laboratories, Cytophil, Inc., Dr. Korman Laboratories, Inamed Corporation, and Anika Therapeutics Inc., and others.


Browse More Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Odontogenic Tumor Market Analysis, Market Growth and Dynamics Forecast

Odontogenic Tumor Market Regional Analysis
The Americas is expected to dominate the global odontogenic tumor market during the forecast period owing to the increasing prevalence of odontogenic tumor diseases along with the growing geriatric population and well-established healthcare sector in the region. The European market is expected to be the second-largest due to government funding and support from the healthcare sector, coupled with increasing research and development.
Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing market during the forecast period owing to technological developments, an increasing number of advanced surgeries in emerging economies, and favorable government initiatives for healthcare facilities. The Middle East and Africa is anticipated to hold the smallest share of the global odontogenic tumor market. The market growth in this region can be attributed to the increasing healthcare expenditure and lack of awareness among the people regarding odontogenic tumor in children.
Odontogenic Tumor Market Highlights

The odontogenic tumor is the abnormal growth of cells in and around the jaws and teeth. Many of these tumors are benign. In usual cases, odontogenic tumors are malignant means they are likely to spread in jaws and teeth.  This tumor can be diagnosed using different techniques such as computerized tomography scan (also called a CT or CAT scan), magnetic resonance imaging (MRI), and biopsy. The increasing incidence of the odontogenic tumor and other dental-related diseases, rising geriatric population, and increasing incidence of children suffering from an odontogenic tumor and dental clinics are anticipated to drive the growth of the market during the forecast period.
However, unfavorable reimbursement scenario and lack of awareness among the people regarding odontogenic tumor may hamper the growth of the market during the assessment period. The global odontogenic tumor market is dominated by many market players. The key players in the market are engaged in new launches and strategic collaborations to hold their market position. 

Odontogenic Tumor Market Segmentation
The global odontogenic tumor market is segmented into types of tumor, diagnosis, treatment, and end-user. Based on types of tumor the odontogenic tumor market is segmented into two segments, namely,  malignant odontogenic tumors and benign odontogenic tumors. Malignant odontogenic tumors are further sub-segmented into ameloblastic carcinoma, primary intraosseous carcinoma, NOS sclerosing odontogenic carcinoma, clear cell odontogenic carcinoma, ghost cell odontogenic carcinoma, odontogenic carcinosarcoma, and odontogenic sarcomas.

Benign odontogenic tumors are further segmented into epithelial origin, mixed (Epithelial-Mesenchymal) origin, and mesenchymal origin. Epithelial origin is further sub-segmented into ameloblastoma, conventional, squamous odontogenic tumor, calcifying epithelial odontogenic tumor, and adenomatoid odontogenic tumor. Mixed (Epithelial-Mesenchymal) origin is further sub-segmented into ameloblastic fibroma, primordial odontogenic tumor, odontoma, and dentinogenic ghost cell tumor. Mesenchymal origin is further sub-segmented into odontogenic fibroma, odontogenic myxoma/myxofibroma, cementoblastoma, and cemento-ossifying fibroma. On the basis of diagnosis, the odontogenic tumor market is further segmented into computerized tomography scan (also called a CT or CAT scan), magnetic resonance imaging (MRI), and biopsy. Based on treatment, the odontogenic tumor market is further segmented into surgery, radiation therapy, and chemotherapy. Based on end-user, the odontogenic tumor market is further segmented into hospitals, dental clinics, dental laboratories, dental academics, and research institutes.
Odontogenic Tumor Market Key Players

Some of the key players in the global odontogenic tumor market are Midwest dental Inc, Burkhart Dental Supply Co., Inc, Delta Dental Plans Association, Patterson Dental Supply, Inc, DeCare Dental, LLC, Oral Cancer Prevention International, Inc, Zila, Inc, Altima Dental Canada, Inc, OraTec Corporation, Oral health innovation Ltd, Senior Dental Care, LLC, and Amerident Dental Inc.


Browse More Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Lancet and Pen Needles Market Solutions, Services, Opportunities and Challenges

Lancet and Pen Needles Market Segmentation
The Asia Pacific lancet and pen needles market is segmented on the basis of therapy, gauge, needle length, and end users.

On the basis of the therapy, the market is segmented into insulin, glucagon-like peptide-1 (GLP-1), growth hormones, and others.
On the basis of the gauge, the market is categorized into 17/18G, 21G, 23G, and others.
On the basis of the needle length, the market is segmented into 4mm, 8mm, 12mm, and others.
On the basis of end users, the market is segmented into hospitals & clinics, medical institutions & research organizations, and others.

Lancet and Pen Needles Market Highlights
The Asia Pacific lancet and pen needles market size is expected to grow at a CAGR of 6.5% during the forecast period. Lancet and pen needles are extensively utilized for the monitoring, diagnosis, and medication of several diseases such as diabetes and osteoporosis. The increasing prevalence of diabetes and osteoporosis within the Asia Pacific region majorly drives the market growth. In 2016, a study was conducted by the American Diabetes Association, which stated that about 80% of the diabetic patients resides in the developing countries. It was also estimated that the rise of type 2 diabetes in South Asia may grow by over 150% from 2000 to 2035.
Moreover, in the Western Pacific region, the number of diabetic patients is expected to rise to 201.8 million by 2035. Additionally, according to the International Osteoporosis Foundation by 2050, over ~50% of all osteoporotic hip fractures are projected occur in Asia. Additionally, increasing geriatric population and growing healthcare expenditure along with favorable government policies may boost the market growth during the forecast period.  However, the need to remove the pin after a single use and the high cost as compared to the insulin vials may restrain the market growth during the forecast period.

Lancet and Pen Needles Market Regional Analysis
On the regional basis Asia Pacific is segmented into Japan, India, China, the republic of Korea, Australia and the Rest of Asia Pacific.

Japan holds a major share of the market followed by the republic of Korea and Australia owing to well-developed healthcare sector and high per capita healthcare expenditure. Moreover, growing geriatric population boosts the market growth during the forecast period.

China and India has a growing market due to huge population base, rapidly changing economy, increasing healthcare expenditure, and rising number of pharmaceutical & biotechnological companies.
According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector is estimated to be one of the fastest growing region and is expected to grow at a CAGR of 22.87% and reach USD280 billion by 2020. Moreover, increasing number of healthcare organizations like hospital, private research institute has led the market growth in India. Rest of Asia Pacific holds the least share of the market.
Lancet and Pen Needles Market Key Players

Some of the key players in the Asia Pacific lancet and pen needles market are BD. (U.S.), Novo Nordisk A/S (Europe), Ypsomed (Europe), B. Braun Melsungen AG (Europe), HTL-STREFA (Europe), Terumo Corporation (Asia Pacific), Artsana S.p.A. (Europe), Owen Mumford Ltd. (Europe), and others.


Browse More Related Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

U.S. Medical Sector Contract Electronic Manufacturing Market Growth, Size, Dynamics

U.S. Medical Sector Contract Electronic Manufacturing Market
North America dominates the Americas U.S. medical sector contract electronic manufacturing market. North America is further segmented into the U.S. and Canada. The market exhibits growth opportunities due to advancement in robotics, and presence of key players in the market. The U.S. contract electronic manufacturing industry is known for its highly automated nature. According to the Robotics Industries Association (RIA), 2014 was an extremely successful year with robots valued at USD 1.6 billion were ordered by North American companies representing an increase of 28% in units and 19% in dollars over 2013. Although the automotive industry leads in the use of robotics, the semiconductor and electronics industry reflected a 21% increase in demand of robots in the year 2014 over 2013.

U.S. Medical Sector Contract Electronic Manufacturing Market Overview
The U.S. medical sector contract electronic manufacturing market size is expected to grow at CAGR 8.8% by 2022. Technological advancements, product development, and economics of production and trade are major factors that drive the growth of the market. However, there are various factors that hamper the market growth such as high cost of labour, structural changes in industry and employment, standardization and interoperability, and others. The advent of positron emission tomography (PET) is expected to revolutionize as it enables the study of metabolic processes in the body.

Key Players in the U.S. Medical Sector Contract Electronic Manufacturing market
Benchmark Electronics, Inc., Flex Ltd. Celestica Inc., Jabil Circuit Inc., Sanmina Corporation, Nortech Systems, Inc., TE Connectivity Corporation, Forefront Medical Technologies and others.

U.S. Medical Sector Contract Electronic Manufacturing Market Key Developments
Strategic approaches adopted help the major players to sustain their growth in the market and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players.
Benchmark Electronics, Inc. is a U.S. based company, is involved in providing services for integrated electronics manufacturing services (EMS), engineering and design services, and precision machining services.
The company announced the acquisition of Secure Communication Systems, Inc. a deal of USD 230 million. This agreement is expected to enhance benchmark's margins and earnings per share
The company announced its expansion in Israel by opening a new design centre in Haifa. This expansion will enhance the companies R&D activities in Israel

The company announced its partnership with iHear Medical that will advance the hearing products of iHear. In this partnership, Flex will serve as the Company's primary manufacturer and supplier
Sanmina Corporation communications networks, defence and aerospace, industrial and semiconductor systems, medical, multimedia, computing and storage, automotive and clean technology sectors.
The company announced its agreement with Ouraring to develop advanced wearable device for enhancing sleep quality and performance. According to this agreement Sanmina Corporation will provide end-to-end solutions for developing new smart wearable device
The company provides services to wide range of industries that include aerospace, autosport, rail, communication & wireless equipment, defence, medical & healthcare, automotive, oil & gas, marine, sensor solutions and many others.

The company announced the complete acquisition of the Creganna Medical Group; company involved in productions of minimally invasive delivery and access devices for medical device original equipment manufacturers (OEMs). This acquisition is a strategy to maintain the industry leadership
The company announced its agreement to acquire AdvancedCath for USD 190 million USD in cash. AdvancedCath is one of the leader in advanced catheter systems. This acquisition will eventually enhance and significantly expands TE's connectivity and sensor position in the attractive medical device market
The company announced the complete acquisition of Measurement Specialties, Inc. one of the leader in global designer and producer of sensors and sensor-based systems. The acquisition of Measurement Specialties establishes TE as a leader in the very attractive high-growth sensor market


Browse More Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Blood Glucose Test Strip Packaging Market Analysis, Development Trend and Investment Feasibility

Blood Glucose Test Strip Packaging Market Segmentation:
The global blood glucose test strip packaging market has been segmented on the basis of product type. Based on product type, the blood glucose test strip packaging market is segmented into plastic vials, aluminum foils and others. The plastic vials segment is sub-segmented into plastic vials with loose desiccant, plastic vials with injected desiccant, plastic vials with other desiccant and plastic vials without desiccant.

Blood Glucose Test Strip Packaging Market Overview:
The blood glucose test strips are enclosed in high barrier pouches and vails in order to protect their quality from getting deteriorated due to environmental factors such as moisture, bacterial contamination and others. As per the report that has been published by Market Research Future (MRFR), the global blood glucose test strip packaging market is registered to expand steadily in the coming years.

Blood Glucose Test Strip Packaging Market Drivers and Restraints:
Increasing demand for blood glucose test strips due to rise in prevalence of diabetes in all the regions of the world and rapid adoption of self-blood glucose testing devices are majorly propelling the expansion of the global blood glucose test strip packaging market. Innovation in the manufacturing process by the incorporation of advanced technology has significantly improved the quality of packaging, which in turn is fueling the growth of the global blood glucose test strip packaging market.

Increasing geriatric population, prevalence of obesity and diabetes and the adoption of flexible packaging solutions are some of the other factors that are driving the global blood glucose test strip packaging market. However, poor healthcare facilities in the underdeveloped regions and lack of awareness are likely to impact negatively on the growth of the global blood glucose test strip packaging market.

Blood Glucose Test Strip Packaging Market Regional Analysis:
Geographically, the global blood glucose test strip packaging market has been segmented into four major regions such as North America, Europe, Asia Pacific and the Middle East and Africa. Among these, The North America region is projecting dominance over the global blood glucose test strip packaging market owing to the high demand for blood glucose test strips as the prevalence of diabetes is increasing in this region.
The blood glucose test strip packaging market in the Europe region is growing at a noteworthy rate due to the high prevalence of diabetes and obesity and high adoption of self-blood glucose testing in this region. Increasing incidences of diabetes in the Middle East region is fueling the growth of the global blood glucose test strip packaging market in this region. Whereas, lack of awareness is likely to hamper the growth of blood glucose test strip packaging market in the Middle East and Africa region during the forecast period.

Blood Glucose Test Strip Packaging Market Updates:

SVAM Packaging Industries Pvt Ltd, an India-based manufacturer of healthcare and food packaging, has partnered with Japanese packaging giant and one of the world's finest technology driven aluminum company, Toyo Aluminum K.K.
Selected lots of Roche's Accu-Chek Aviva and Accu-Check Performa test strips were recalled due to manufacturing and packaging issues that had caused strip error and biased results.


Blood Glucose Test Strip Packaging Market Key Players:
The leading players that are profiled by MRFR in the report on the global blood glucose test strip packaging market are CSP Technologies (the U.S), Sanner (the U.S), Multisorb Technologies (the U.S), Impak Corporation (the U.S), Laminated films & Packaging (LF&P), INC (the U.S), Flow Dry TechnologY, INC. (the U.S), LPS Industries, LLC (the U.S), Roche Diagnostics, Abbott Laboratories, Lifescan, Inc. (A Johnson & Johnson Company), I-Sens, Inc., Trividia Health (Previously Known As Nipro Diagnostics, Inc.), Ascensia Diabetes Care Holdings Ag (Previously Known As Bayer Diabetes Care), Apex Biotechnology Corporation, Agamatrix Inc., Taidoc Technology Corporation, Universal Biosensors, Beijing Yicheng Electronic Co., Ltd., Sannuo Biosensor Inc., Shanghai Microsense Tm Inc., Acon Laboratories, Inc., Allmedicus, National Diagnostic Products, Hmd Biomedical, Yuwell-Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., 77 Elektronika Kft., B. Braun Melsungen Ag and others.

Browse More Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Americas Medical Rubber and Balloon Product Market Analysis, Growth Impact and Demand By Regions

Americas Medical Rubber and Balloon Product Market Regional Analysis
Americas medical rubber and balloon product market is expected to see strong growth during the forecast period due to increasing need of medical equipment accessories and surgical products as well as growing technological advancements in the formulation of rubber and polymers in the medical device, equipment and accessories industry. Americas medical rubber and balloon market is segmented into North America and South America. North America holds the major share in the market owing to increase in number of diseases which has ameliorate the number of hospitals and surgeries, increasing demand for the different medical devices and rapidly developing technology. Whereas, South America has the developing market.

Americas Medical Rubber and Balloon Product Market Highlights
Rubber and its product have completely improved the safety and efficiency of the medical devices. Rubber is used in the preparation of different medical products such as chloroform bellow, infant syringe, ear /eye and ulcer syringe, dental product, and others. Now a days, rubbers are used to prepare disposables, which have been adopted by peoples and number of organizations. Disposables are one time use and reduces the chances of infection. Different types of size and shapes are available as per the convenience of the user.

However, the most important thing to be considered by manufacturer is the rubber product should not make any kind of allergic reaction to the skin of doctors or patients as different types of colours and chemicals are used while manufacturing of this product. As the prevalence of diseases is increasing continuously the demand of this type of product is increased in developed countries. The major driving factor for the Americas medical rubber and balloon product market are increasing demand for the medical devices & products, increasing prevalence of different chronic diseases, and many brighter sides of the rubber products. On the other hand, introduction of better alternatives may slow the market growth.

Americas Medical Rubber and Balloon Product Market Segmentations
The Americas medical rubber and balloon product market is segmented on basis types, products, technologies, and applications
On the basis of type, the market is segmented into natural rubber, butadiene rubber, butyl rubber, isoprene rubber, silicon rubber, and others.
On the basis of product, the market is segmented into caps, infusion and transfusion sets, birth control products, medical masks, catheters, bulb syringe, rubber bladders, and others.
On the basis of technologies, the market is segmented into non-compliant type and semi compliant type, and others.
On the basis of application, the market is categorised into anchoring, aspiration, drug delivery, occlusion & sizing, stent, valve sizing, and others.

Americas Medical Rubber and Balloon Product Market Key Players
The Americas medical rubber and balloon product market is highly fragmented with the presence of many local and international players. To sustain the increasing competition, local players are focusing on cost reduction and innovation to ensure sustainability. While, the international players implemented growth strategies through collaborations and partnerships to expand their overall market share.

Some of the major players in this market are: Boston Scientific Corporation (US), The Hygenic Corporation (US), Fluke Corporation (US), Allied Healthcare Products, Inc. (US), Cardinal Health (US), INTEGRA Biosciences AG (Switzerland), Abbott (US), Cook (US), Ohio Medical (US), Garware Bestretch Limited (India).


Browse More Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Middle East And Africa Diabetes Treatment Market Insights, Overview, Trends

Middle East and Africa Diabetes Market Segmentation:
Middle East and Africa has led to the rapidly growing diabetes market and expected to reach US$ 16.4 million By 2023

Middle East and Africa Diabetes Market has been segmented on the basis of type which comprise Type 1, Type 2, and Gestational diabetes. On the basis of test, market is segmented into Random blood sugar test, Fasting blood sugar test, Oral glucose tolerance test, Initial glucose challenge test and others. On the basis of devices, it is segmented into Blood glucose monitoring devices, Diabetes management devices, and others. On the basis of treatment market is segmented into Medications, Insulin therapy, Transplantation, Bariatric surgery and others.

Middle East and Africa Diabetes Market Highlights
The Middle East and Africa Diabetes Market has been evaluated as rapidly growing market and it is expected that the market will continue to grow similarly in the near future. This chronic disease can lead to severe medical conditions such as stroke, heart attack or kidney failure. From last two decades, the prevalence of diabetes has increased rapidly in Middle East and Africa region and about 10% of the population is suffering from diabetes. Due to lack of body activity or exercise and eating unhealthy and junk food are leading the growth for the market. In countries like Saudi Arabia, Kuwait, Bahrain, Qatar and UAE, about 24%, 23%, 22%, 20% and 19% of population is affected by this disease respectively. These countries are among the countries with the highest prevalence of this disease. Many countries are facing the burden of diabetes is mostly because of ageing population while in this region, diabetes is rising in all age groups.

Large portion of younger population is suffering from diabetes which is very serious problem and burden on healthcare system of Middle East and Africa region. Type 2 diabetes is most common type of diabetes in this region and it is observed to be most common in men than women. Increasing number of diabetes patients is key driver for the market. Rising middle class population, increasing per capita income results into increasing expenditure on healthcare services is leading to the growth of the market for diabetes in this region. Top class healthcare infrastructure and facilities, technological advancement and availability of skilled medical professionals plays an important role in growth of this market. Government initiatives and commitment to improve public health are also key drivers for the market. Pharmaceutical and device manufacturer companies are focusing on this market and spending money in R&D to deliver innovative product for the patients which can help them to capture maximum market share.

Middle East and Africa Diabetes Market was about USD 11.6 billion in 2016 and is expected to reach USD 16.4 billion by 2023 at a CAGR of 5.1%.

Middle East and Africa Diabetes Market Players:
There are plenty of large and small market players which operate in Middle East and Africa diabetes market are: Abbott (US), Bayer AG (Germany), Becton Dickinson and Company (US), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Roche Diabetes Care, Inc. (US), sanofi-aventis U.S. LLC (US), Ypsomed (Switzerland)

Middle East and Africa Diabetes Market Regional Analysis:
Considering the scenario of the Middle East and African diabetes market, Saudi Arabia is believed to be the largest market for diabetes. Moreover, the UAE is also growing and is the second largest market for Middle East and Africa Diabetes. On the other hand, Egypt market is expected to grow at significant rate in the Middle East and Africa diabetes market during the forecasted period. Rest of Middle East and Africa is likely to have a limited but moderate growth in the market.


Browse More Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Asia-Pacific Glaucoma Treatment Market Analysis, Landscape and Growth Prospects

Asia-Pacific Glaucoma Treatment Market Key Players:
The major participants of this Asia pacific glaucoma treatment market are: Novartis AG, Pfizer Inc., Allergan, Merck & Co., Ocular Therapeutix Inc, pSivida Corp, Icon Bioscience Inc, Amorphex Therapeutics LLC., Ellex, Quantel, Lumenis, and Lightmed and others.

Asia-Pacific Glaucoma Treatment Market Highlights
Glaucoma is the buildup of pressure due to accumulation of eye fluids which may result in permanent blindness due to damage to the eye nerve endings. In fact glaucoma is the second most reason after cataracts causing permanent blindness. Open angle glaucoma (OAG) is the most common type of glaucoma followed by closed angle glaucoma (CAG) and these two accounts for greater than 50% of glaucoma cases. Other types of glaucoma are pigmentary glaucoma, pseudo exfoliation glaucoma and normal-tension glaucoma.
The Asia pacific glaucoma treatment market is growing due to factors such as rising geriatric population and rising cases of diseases such as diabetes. Other market drivers include increasing awareness, growing healthcare expenditure and screening rates.

The constraints of the market are excellent efficacy of the present drugs especially the prostaglandin analogs which are the market leaders. The other constraints are the low penetration of healthcare in poor regions of Asia, the neglect of eye care as compared to other healthcare sectors and the high cost of eye surgeries.
The market developments include the technological advancements in surgeries such as advanced technology glaucoma surgery (ATGS) which involves implant of a drainage device so as to drain the fluids. Micro-invasive glaucoma surgery (MIGS) drainage implants dominate the advanced technology glaucoma surgery (ATGS) devices and are expected to account for most of the growth.
Another development include goggles that help normalize the difference between intraocular pressure (IOP) and cerebrospinal fluid.

Asia-Pacific Glaucoma Treatment Regional Analysis:
The healthcare sector of Asia Pacific varies immensely by countries. However the Asia Pacific region has lower public sector expenditure and most treatments involve out of pocket expenditure. Further the eye care has been a neglected segment especially in the poor countries of Asia Pacific region. Japan and South Korea are the leading markets while China will be the fastest growing due to rising healthcare expenditure and faster economic growth. Also the presence of strong generics especially in nations like India will lead to volume growth of anti-glaucoma drugs. The surgery market however will see fastest growth in Japan as compared to developing parts of Asia Pacific.
Asia-Pacific Glaucoma Treatment Market has been segmented on the basis of disease indication which comprises Closed Angle Glaucoma (CAG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other. On the basis of drug class; market is segmented into prostaglandin analogs (PGAS), alpha agonist, beta blockers, cholinergic drugs, carbonic anhydrase inhibitors, and others. On the basis of surgery; market is segmented into laser iridotomy, laser trabeculoplasty, aqueous shunt surgery and peripheral iridectomy. On the basis of end users; market is segmented into hospitals and home users



About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Neuromodulation Devices Market Study of Key Players, Profile and Dynamics

Neuromodulation Devices Market Regional Analysis
On the regional backgrounds the Americas leads the global neuromodulation devices market owing to a well-developed healthcare sector, huge patient population and presence of the developed technologies like U.S. and Canada which have technological backgrounds and rising healthcare expenditure for facilitating the market growth. Europe is second in the market due to huge patient population, rising government support and increasing awareness about the disease. The Asia Pacific region is the fastest growing region due to the developing economies like India and China which have a developing healthcare sector. On the other hand, the Middle East and Africa have the least market share, especially in the African region due to the presence of poor economies and stringent government within the African region. The Middle East region holds the market within this region due to huge healthcare expenditures.  

Neuromodulation Devices Market Overview
The Global neuromodulation devices market is growing with a sound pace. According to a recent study report published by the Market Research Future, the global neuromodulation devices market is booming and expected to gain prominence over the forecast period. The market is projected to demonstrate a sound growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2027).

Neuromodulation is a technology that acts directly upon the nerves, thereby, causing alterations in the nerve activity. This is achieved by delivering electrical or pharmaceutical agents directly onto the target area. There is a plethora of neuromodulation applications, which includes deep brain stimulation (DBS) treatment for Parkinson's disease, sacral nerve stimulation for pelvic disorders and incontinence, and spinal cord stimulation for ischemic disorders. Increasing prevalence of neurological disorders like Alzheimer’s and Parkinson’s diseases, and growing geriatric population are the major drivers for the market growth during the forecast period.
According to the Alzheimer's Association in 2017, 5.5 million Americans live with Alzheimer's disease and about 5.3 million of this patient population age is 65 years or more. Moreover, according to the World Health Organization, the number of people who age 65 or older is projected to grow from 524 million in 2010 to approximately 1.5 billion by 2050. Moreover, it was estimated that most of the increase in the geriatric population will be witnessed in the developing countries. Additionally, increasing awareness of about neurological disorders will fuel the market growth during the forecast period. However, high cost of the treatment procedures followed by the stringent government policies and low per capita healthcare expenditures in the middle- and low-income countries may restrain the market growth.

Neuromodulation Devices Market Competitive Analysis
Medtronic (Ireland), Accellent (U.S), St. Jude Medical, Inc. (U.S.), Synapse Biomedical Inc. (U.S.), Nevro Corp (U.S.), DynaMD, Boston Scientific Corporation (U.S.), NeuroSigma, Inc.(U.S.), NeuroPace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Soterix Medical Inc. (U.S), and BioControl Medical (Israel) are some of the prominent players at the forefront of competition in the Global Neuromodulation Devices Market and are profiled in MRFR Analysis.
Characterized by the presence of several well-established and small players, the global neuromodulation devices market appears to be highly competitive and fragmented. International players are expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product portfolios, quality, and pricing.  The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.
Medtronic is one of the significant players of the global neuromodulation devices market. The company was founded in 1949 and is headquartered in Ireland. Medtronic’s annual sale in 2015 was USD 20,261 million and reached USD 28,833 million in 2016. Such significant increase in the sales lead to a huge investment in the R&D. In 2016, the company invested 7.7% of its total revenue into the research and development processes.
In October 2016, Medtronic got an approval for its suite of cardiac rhythm and heart failure devices. This advancement gave patients- Medtronic SureScan MR-conditional pacemakers, implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds). This helped Medtronic to strengthen its position in the market.

In September 2016, Boston Scientific and EndoChoice Holdings, Inc. announced that the companies have entered into a definitive agreement under which Boston Scientific had agreed to acquire EndoChoice. Upon completion of the transaction, EndoChoice became part of the Boston Scientific endoscopy business.


Browse More Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

at No comments:

Neuropsychiatric Disorders and Treatment Market Size, Type, Application

Global Neuropsychiatric Disorders And Treatment Market Research Report, By Disorders (Degenerative Diseases, Neurotic Disorders, Psychosis And Others), By Treatments (Shock Treatment, Drug Treatment, Others) By End Users (Hospitals, Clinics, Research Centers And Others) - Forecast Till 2023
Neuropsychiatric Disorders and Treatment Market Competitive Analysis

Many factors are fueling the growth of the Neuropsychiatric Disorders and Treatment Market Growth. This has attracted many of the manufacturer for development of the market in this sector. Increasing in alliances amongst the leading player has helped to introduction of new and better treatment for the neuropsychiatric disorders.
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company headquartered in UK. Recently AstraZeneca has completed its collaboration with National Institute of Mental Health. This collaboration will help to discover the new and better drug treatment for distressing condition. AstraZeneca has also collaborated with Vanderbilt Center for the Neuroscience Drug Discovery which aims to discover new drug for the treatment of neuropsychiatric disorders.

Universal Health Services is an American Fortune 500 company headquartered in US. It is one of the largest hospital management companies in US. Universal Health Services is a huge company with the revenues of nearly USD 9.7 billion with the profit of more than USD 600 million.
Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies headquartered in Germany. In 2016, Boehringer Ingelheim is collaborated with Saniona. This collaboration aims to develop the new treatment for the patients suffering from schizophrenia.

Neuropsychiatric Disorders and Treatment Market Overview
Neuropsychiatric disorders are mental disorder occur due to disturbance in the function of cerebral system. Neuropsychiatric disorders are most common to the people having more than 65 year’s age. Increasing prevalence of neuropsychiatric disorders across the globe is the major reason for driving the market. Beside this increasing demand for the better treatment and development in the healthcare sector are the major driving factor for the growth of the market.  While lack of clinical trial data for neuropsychiatric drugs and long term treatment of this diseases may restrain the growth of the market.

Geographically, North America accounts for the largest neuropsychiatric disorders and treatment market which is slightly less than Europe. Huge population suffering from neuropsychiatric disorders in this region is the major reason for the development of the market. According to WHO the number of patients suffering from neuropsychiatric disorders will be doubled in next couple of decades due to increasing aging population in North America and Europe. Asia Pacific has the third leading market which is expecting a fastest growth in this market due to rapid development in healthcare sector and increasing demand for the better treatment of the neuropsychiatric disorders.

Neuropsychiatric Disorders and Treatment Market Regional Analysis
On regional basis, global neuropsychiatric disorders and treatment market is segmented into North America, Europe, Asia Pacific and Middle East and Africa. North America commands the largest market for the neuropsychiatric disorders and treatment. In North America neuropsychiatric disorders account the highest rate of disability-adjusted life year (DALYs). DALYs is a measure of overall disease burden which express the number of years lost due to ill health or early death. According to Centers for Disease Control and Prevention, around 5.3 million Americas are suffering from this disease and this number is expected get double in next couple of decades due to due to the aging of the population.

Europe commands the second largest market for the neuropsychiatric disorders and treatment. Huge population suffering from mental disorders in Iceland, Norway and Switzerland has contributed a lot for the European market. Moreover, increasing demand for need of better treatment and increasing burden of neuropsychiatric disorders are the major factor for the growth of the market.
Neuropsychiatric disorders and treatment market in Asia Pacific is growing at a steady pace due to huge geriatric population in this area, continuous improving healthcare infrastructure and rapid development in healthcare sector has boosted growth of this market. The Middle East and Africa has least market for the neuropsychiatric disorders and treatment.


Browse More Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Suture wire Market Share, Trend, Challenges, Segmentation

Suture wire market research report, by type (absorbable, non-absorbable), by application (surgery, veterinary, and other) by end users (hospitals, clinics, other) - global forecast till 2023

Suture Wire Market Competitive Analysis
The major key player for the global Suture wire Market are Boston Scientific Corporation (US), Demetech Corporation (US), Endoevolution Llc (US), Ethicon Inc. (US), Apollo Endosurgery Inc. (US), B. Braun Melsungen AG (Germany), Smith & Nephew Plc. (UK), Surgical Specialties Corporation (Germany), Sutures India Pvt Ltd (India), Internacional Farmacéutica S.A. (US), Medtronic PLC (UK), Peters Surgical (France), Covidien Plc. (UK), Jiangxi Longteng Co. Ltd. (China),  DemeTech (US), Teleflex Incorporated (US), Lotus Surgicals Pvt Ltd. (India)
Suture market across the globe is continuously changing due to acquisition of local manufactures with multinational companies. Some companies are focusing on the new product developments while some has adopted strategies of acquisitions and strategic alliances for the growth of the market.

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices. A wide range of products of this company are available in market. Company has acquired Schneider and EP Technologies. Different types of suture wire having different diameter are available in the market. The market of this company is increased by 12% in 2016 compare to 2015.

DemeTech Corporation is a world-renowned leader in surgical sutures and blades headquartered in US. Company has provided sutures of paramount quality at a lower and more reasonable cost which has increased the market of company. Polypropylene Sutures wire and Silk Sutures wires are famous product of the company and generate major amount of revenue. Company is majorly focusing on development of the new product to increase the product range.
Medtronic is a medical device manufacturer headquartered in UK. It is the world's largest standalone medical technology development company. Company has a wide range of absorbable and non- absorbable products. Company recently introduced V-Loc wound closure device which is a revolutionary technology that eliminates the need to tie knots, so that the physician can close incisions up to 50% faster without compromising strength and security. Dermalon, Monosof, Surgilon and Surgidac are some of the non- absorbable products. Maxon is a veterinary suture manufactured by company.

Suture Wire Market Highlights
Suture wire Market size is expected to Reach CAGR of 9.8% during Forecast period 2017-2023-Suture wires are the thread like medical device which are used during the surgeries for holding body tissue. Suture wire is using since ancient time for the treatment but development in the material of the wire has increased their application in medial field. Global suture wire market is driven by introduction on new and better material for suture wire and increasing prevalence of different chronic diseases. Changing lifestyle, increasing aging population and increasing governmental support for research has also driven the market. On other hand, strict regulatory rules and high cost of surgeries has restrained the growth of market.

Suture Wire Market Segmentation:
Global suture wire market is segmented based on type, application and end users. Based on type the market is segmented into absorbable suture and non-absorbable suture. Absorbable suture is sub segmented into polyglycolic acid, polylactic acid, polydioxanone and monocryl. Non- absorbable sutures are sub segmented into nylon, polyester, polypropylene and other. Based on application, the market is segmented into surgery, veterinary, and other. Surgery is further sub segmented into cardiac, renal, dental and other. On the basis of end users, it is segmented into hospitals, clinics and other.


Browse More Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:
Subscribe to: Posts (Atom)

Ultra-low Temperature Freezers Market Profile, Trends and Applications By 2027

  According to the MRFR reports, the global   ultra-low temperature freezers market   is projected to acquire a market size of approximately...